The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL

about

The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL

Item

http://www.wikidata.org/entity/Q57200151

description

im November 2010 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2010

@uk

name

The negative prognostic value ...... eutic use of recombinant TRAIL

@en

The negative prognostic value ...... eutic use of recombinant TRAIL

@nl

type

Item

label

The negative prognostic value ...... eutic use of recombinant TRAIL

@en

The negative prognostic value ...... eutic use of recombinant TRAIL

@nl

prefLabel

The negative prognostic value ...... eutic use of recombinant TRAIL

@en

The negative prognostic value ...... eutic use of recombinant TRAIL

@nl

P1476

The negative prognostic value ...... eutic use of recombinant TRAIL

@en

P2093

Alex Knowles

http://www.w3.org/2001/XMLSchema#string

Annalisa Palmieri

http://www.w3.org/2001/XMLSchema#string

Corrado Rubini

http://www.w3.org/2001/XMLSchema#string

Daniela Stramazzotti

http://www.w3.org/2001/XMLSchema#string

Elisabetta Melloni

http://www.w3.org/2001/XMLSchema#string

Francesco Carinci

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor

Squamous cell carcinoma of the oral tongue in the pediatric age group: a matched-pair analysis of survival.

Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer.

Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis.

Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.

Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression.

HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis.

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.

P2888

s10637-010-9586-0

P304

810-818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10637-010-9586-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21086019

http://www.w3.org/2001/XMLSchema#string

P921

overexpression